Labeler · US market

Methapharm Inc.

Methapharm Inc. is a US drug labeler with US FDA registrations covering 5 drug concepts (4 currently active) across 6 packages. It is currently the only active US supplier of 4 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes64281 · 67850

Active drugs4

Registrations5 active / 6

Packages6

Sole supplier of4 drugs

Portfolio5 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Polidocanol injection, solution	rx	2	2	SUPPLYING
Methacholine Chloride Inhalation Solution kit	rx	1	1	SUPPLYING
Methacholine Chloride powder, for solution	rx	1	1	SUPPLYING
Methacholine Chloride Inhalation Solution solution	rx	1	1	SUPPLYING
Mannitol kit	rx	1	1	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes64281, 67850
Filing names1
Drugs (active)4
Drugs (all time)5
US registrations6
Packages6

Recent events

Shortages, recalls, and registration changes across all filing names.

Apr 7, 2023
RECALLRecall (Class II): Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous Infusion Only, Mfd. for Metha…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.